Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_provenance.
- NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_provenance.
- NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_assertion evidence source_evidence_literature NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_provenance.
- NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_assertion SIO_000772 21720365 NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_provenance.
- NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_assertion wasDerivedFrom befree-2016 NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_provenance.
- NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_assertion wasGeneratedBy ECO_0000203 NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_provenance.